Cite
MLA Citation
Jaime S. Horton et al.. “"TRPV1 is a component of the atrial natriuretic signaling complex, and using orally delivered antagonists, presents a valid therapeutic target in the longitudinal reversal and treatment of cardiac hypertrophy and heart failure".” Channels, vol. 13, no. 1, 2019, pp. 1–16. http://access.bl.uk/ark:/81055/vdc_100075228972.0x000007